Popular Articles

Rising Lifestyle Illnesses And Potential Swine Flu Catastrophe For Indigenous Populations
The first of two reviews in this week"s edition of The Lancet discusses the standards of health and lifestyles of Indigenous people. It is the work of Professor Michael Gracey, of the Unity of First People of Australia, Perth, WA, Australia, and Professor Malcolm King, of the University of Alberta, Edmonton, Canada. There are almost 400 million Indigenous people in the world with low standards of health that are usually linked to malnutrition, poverty, environmental contamination, and prevalent infections. However, as those people shift to more modern or "western" lifestyles, conditions such as obesity, cardiovascular diseases, and type 2 diabetes have been on the rise. Physical, social and mental disorders related to misuse of alcohol and other drugs are also increasing. Indigenous people must be encouraged and given the means to take responsibility for issues that affect their health. In this review, the authors discuss indigenous people worldwide but focus on Aboriginal Australians.
new payday loan lenders
Washington, D.C., Officials Expand STI Testing Program To All Public High Schools
Washington, D.C., officials are planning to make testing for sexually transmitted infections available at all public high schools in the coming school year, adding D.C. to a growing list of cities that test students for STIs, the Washington Post reports. All 50 states and the district allow minors older than age 12 to be tested for STIs without parental consent.The new program requires all students to attend a lecture about STIs, after which they are escorted into restroom areas in groups of 15 to 20. They are then given paper bags with urine collection cups and go into the stalls, at which point they can decide whether to provide a sample. All students return the paper bags, regardless of whether they provided samples. Students give a password and can call a week later to receive their confidential results and, if necessary, treatment at the school or an STI clinic, which is paid for by the city. The district first offered the program two years ago at two charter schools, and eight high schools were included during the past school year.A 2007 study by the D.C. public school system found that 60% of high school students and 30% of middle school students reported having sex. According to the study, 20% of high school students reported having sex with four or more partners and 12% of middle school students reported having three or more partners.According to the D.C. Department of Health, the program at eight high schools last year found that 13% of 3,000 students tested positive for an STI, most commonly chlamydia or gonorrhea. Fifty percent of the chlamydia and gonorrhea cases in the district are among teenagers.According to the D.C. Appleseed Center for Law and Justice, the new program is an important step toward curbing the district"s HIV/AIDS rate, which is among the highest in the U.S. Walter Smith, executive director of D.C. Appleseed, said, "If 13% of these students are testing positive for [STIs], those same kids could get HIV," adding, "A lot needs to be done to get the message out to the schools, ... and this very high [STI] rate is an indication that what we"ve been doing is not effective" (Fears/Hernandez, Washington Post, 8/5).
News of the day
Stem Cell Therapeutics Corp. Announces Publication Of Phase I Stroke Data
Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) is pleased to announce the acceptance and publication of the paper entitled "Open labeled, uncontrolled pharmacokinetic study of single intramuscular hCG dose in healthy male volunteers" by the International Journal of Clinical Pharmacology and Therapeutics, Vol. 47, August 2009. This paper was authored by Drs. Alan Moore, President & CEO, Allen Davidoff, VP Product Development and Yan Yang, Clinical Research Associate, all of SCT; Dr. Michael D. Hill of Foothills Hospital at the University of Calgary, and Dr. Steven C. Cramer, from the University of California, Irvine.
Nutrition

Meda: FDA Approval For Onsolis Anticipated During Summer 2009

Since August 2008, Meda (STO:MEDAA) and BioDelivery Sciences International (BDSI) have worked in close collaboration with the U.S. Food and Drug Administration (FDA) to complete the final requirement of a Risk Evaluation and Mitigation Strategy (REMS) program for Onsolis (fentanyl - treatment of breakthrough cancer pain). Last Friday, FDA"s review Division informed Meda and BDSI that they had reached agreement with the REMS for Onsolis, but that the FDA needed some additional time to complete the final senior level sign off. Meda therefore expects Onsolis to be approved by the FDA during summer, which could enable a fourth quarter 2009 launch, as previously anticipated. MEDA AB (publ) is a leading international specialty pharma company. The company specialises in marketing and pharmaceutical development in late clinical stage. Acquisitions and long-term partnerships drive the company"s strategy. Meda is represented by its own organizations in about 40 countries. Meda"s products are sold in 120 countries worldwide. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange Stockholm. Find out more, visit http://www.meda.se. MEDA AB


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):